Skip to main content
Header image

Alladi Charanraj Goud M.sc, Ph.D.

Journals

OTA, V., L. SPINOLA, G. COSTA, A. GOMES BUGIGA, M. NUNES NOTO, C. MUNIZ CARVALHO, S. LEE, A. LOKMER, C. ALLADI, D. SHEWADE, R. RAJKUMAR, F. BELLIVIER, R. BRESSAN, C. MARIE-CLAIRE, C. NOTO, G. BREEN, S. BELANGERO
Longitudinal DNA methylation and cell-type proportions alterations in risperidone treatment response in first-episode psychosis. Progress in neuro-psychopharmacology & biological psychiatry. 2025, 111402, ISSN: 0278-5846, PMID: 40393579,  PDF.
ALLADI, C., R. RAJKUMAR, D. SHEWADE, L. GOENKA, S. SRINIVASMURTHY
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia. European Journal of Clinical Pharmacology. 2025, ISSN: 0031-6970, PMID: 40172663,  PDF.
GOUD, V., C. ALLADI, S. RAMASSAMY, M. JAYANTHI, R. MEDHA, L. CHANDRASHEKAR
Assessment of Erythrocytes Methotrexate Polyglutamate Three Levels in Psoriatic Patients Treated with Methotrexate Monotherapy and Their Association with Disease Response. Indian journal of clinical biochemistry : IJCB. 2025, 40(1), 86-96, ISSN: 0970-1915, PMID: 39835229,